🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this single-arm, Phase II interventional clinical trial is to t...
Status
Unknown
Location
West China Hospital, Sichuan University
Start Date
2023-07-01
Trial ID
NCT05978609
Treatments Being Tested
A Phase II Study Evaluating the Efficacy and Safety of LM-302 in Combinatio...
Status
Recruiting
Location
Zhongshan Hospital Fudan University
Start Date
2024-07-31
Trial ID
NCT06587425
Treatments Being Tested
This is a prospective, single-arm, open-label，single-center, phase II study...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2023-03-21
Trial ID
NCT05853172
Treatments Being Tested
This study is a single-arm, open-label, multicenter clinical study to evalu...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-07-11
Trial ID
NCT06455254
Treatments Being Tested
This is a prospective, single-arm, open-label，multi-center, phase II study,...
Status
Unknown
Location
Anyang Cancer Hospital
Start Date
2023-08-01
Trial ID
NCT05896787
Treatments Being Tested
To explore the efficacy and safety of candonilimab plus bevacizumab for pat...
Status
Withdrawn
Location
Cancer Center Sun Yat-sen University
Start Date
2022-12-07
Trial ID
NCT05886257
Treatments Being Tested
Objective to evaluate the efficacy and safety of candonilimab combined with...
Status
Recruiting
Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2024-02-28
Trial ID
NCT05926700
Treatments Being Tested
In this clinical study, we will evaluate the efficacy and safety of cardoni...
Status
Active Not Recruiting
Location
Zhongshan hospital, Fudan University
Start Date
2023-08-01
Trial ID
NCT05994001
Treatments Being Tested
To explore the efficacy and safety of candonilimab plus bevacizumab for pat...
Status
Unknown
Location
Cancer Center Sun Yat-sen University
Start Date
2023-02-27
Trial ID
NCT05760599
Treatments Being Tested
The aim of this study is to involve high-risk patients with a history of ma...
Status
Active Not Recruiting
Location
Shanghai Ninth People's Hospital
Start Date
2020-06-30
Trial ID
NCT06728631
Treatments Being Tested